Cooperation between the Hepatitis C Virus p7 and NS5B Proteins Enhances Virion Infectivity.
The molecular mechanisms that govern hepatitis C virus (HCV) assembly, release, and infectivity are still not yet fully understood. In the present study, we sequenced a genotype 2A strain of HCV (JFH-1) that had been cell culture adapted in Huh-7.5 cells to produce nearly 100-fold-higher viral titers than the parental strain. Sequence analysis identified nine mutations in the genome, present within both the structural and nonstructural genes. The infectious clone of this virus containing all nine culture-adapted mutations had 10-fold-higher levels of RNA replication and RNA release into the supernatant but had nearly 1,000-fold-higher viral titers, resulting in an increased specific infectivity compared to wild-type JFH-1. Two mutations, identified in the p7 polypeptide and NS5B RNA-dependent RNA polymerase, were sufficient to increase the specific infectivity of JFH-1. We found that the culture-adapted mutation in p7 promoted an increase in the size of cellular lipid droplets following transfection of viral RNA. In addition, we found that the culture-adaptive mutations in p7 and NS5B acted synergistically to enhance the specific viral infectivity of JFH-1 by decreasing the level of sphingomyelin in the virion. Overall, these results reveal a genetic interaction between p7 and NS5B that contributes to virion specific infectivity. Furthermore, our results demonstrate a novel role for the RNA-dependent RNA polymerase NS5B in HCV assembly.


OBJECTIVE
Hepatitis C virus assembly and release depend on viral interactions with host lipid metabolic pathways. Here, we demonstrate that the viral p7 and NS5B proteins cooperate to promote virion infectivity by decreasing sphingomyelin content in the virion. Our data uncover a new role for the viral RNA-dependent RNA polymerase NS5B and p7 proteins in contributing to virion morphogenesis. Overall, these findings are significant because they reveal a genetic interaction between p7 and NS5B, as well as an interaction with sphingomyelin that regulates virion infectivity. Our data provide new strategies for targeting host lipid-virus interactions as potential targets for therapies against HCV infection.
Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA.
Mounavya
M
Aligeti
Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA.
Allison
A
Roder
Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA stacy.horner@duke.edu.
Stacy M
SM
Horner
D001483:Base Sequence; D045744:Cell Line, Tumor; D016174:Hepacivirus / Q000235:genetics / Q000378:metabolism / Q000472:pathogenicity*; D006526:Hepatitis C / Q000821:virology; D006801:Humans; D066292:Lipid Droplets / Q000502:physiology; D008075:Lipoproteins, HDL / Q000378:metabolism*; D012367:RNA, Viral / Q000096:biosynthesis / Q000235:genetics; D012324:RNA-Dependent RNA Polymerase / Q000235:genetics / Q000378:metabolism; D017423:Sequence Analysis, RNA; D013109:Sphingomyelins / Q000378:metabolism*; D019562:Viral Load / Q000235:genetics; D017361:Viral Nonstructural Proteins / Q000235:genetics / Q000378:metabolism*; D014764:Viral Proteins / Q000235:genetics / Q000378:metabolism*; D014771:Virion / Q000235:genetics / Q000378:metabolism / Q000472:pathogenicity*; D019065:Virus Assembly / Q000235:genetics; D014779:Virus Replication / Q000235:genetics; D000086082:Viroporin Proteins
D008075:Lipoproteins, HDL; D012367:RNA, Viral; D012324:RNA-Dependent RNA Polymerase; D013109:Sphingomyelins; D017361:Viral Nonstructural Proteins; D014764:Viral Proteins; C037977:high density lipoprotein sphingomyelin; C088369:p7 protein, Hepatitis C virus; D000086082:Viroporin Proteins; C087036:NS-5 protein, hepatitis C virus